I tend to disagree with the notion that Allergan would not want to compete against Minoxidil. This is a billion dollar market, and if they have a better product, they have a tremendous incentive.
However, I do see an issue in that their first product will probably be at a concentration that will not be particularly effective for aggressive male pattern baldness, just as Minoxidil was first released in only a 2% concentration. Of course this would not prevent some from boosting the concentration via evaporation, like many did with 2% Minoxidil.
Certainly Bimatoprost's side effects profile seems less than Minoxidil. Only time will tell if it is more effective. Even if only equally effective, I would prefer it over Minoxidil.
I just want something to come to the open market ASAP...
However, I do see an issue in that their first product will probably be at a concentration that will not be particularly effective for aggressive male pattern baldness, just as Minoxidil was first released in only a 2% concentration. Of course this would not prevent some from boosting the concentration via evaporation, like many did with 2% Minoxidil.
Certainly Bimatoprost's side effects profile seems less than Minoxidil. Only time will tell if it is more effective. Even if only equally effective, I would prefer it over Minoxidil.
I just want something to come to the open market ASAP...